Drug Shortage Report for TEVA-TAMSULOSIN CR
| Report ID | 209148 |
| Drug Identification Number | 02368242 |
| Brand name | TEVA-TAMSULOSIN CR |
| Common or Proper name | TEVA-TAMSULOSIN 0.4MG CR TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-01 |
| Estimated end date | 2024-05-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2024-05-03 | French | Compare |